Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, . . . Alexander L. Gintsburg. (2021). An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults. Elsevier.
Chicago Style (17th ed.) CitationAmir I. Tukhvatulin, et al. An Open, Non-randomised, Phase 1/2 Trial on the Safety, Tolerability, and Immunogenicity of Single-dose Vaccine "Sputnik Light" for Prevention of Coronavirus Infection in Healthy Adults. Elsevier, 2021.
MLA (9th ed.) CitationAmir I. Tukhvatulin, et al. An Open, Non-randomised, Phase 1/2 Trial on the Safety, Tolerability, and Immunogenicity of Single-dose Vaccine "Sputnik Light" for Prevention of Coronavirus Infection in Healthy Adults. Elsevier, 2021.